|
|
|
| home > white papers > Bringing more control to temperature-sensitive logistics - UPS Supply Chain Solutions |
|
|
 WHITE PAPERS |
|
|
UPS Supply Chain Solutions
|
|
Bringing more control to temperature-sensitive logistics
|
|
By 2016, world sales of cold-chain drugs and biologics such as vaccines
and blood plasma products will near $240 billion1. The increase has led
to a surge in discussion about how to protect these products throughout
the transportation logistics cycle. Industry experts are recommending
that the term “cold chain” be eliminated from rules, guidance and
best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room
temperature (CRT). This white paper focuses on the initial steps
required to establish a temperature-sensitive supply chain.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline
Sanofi announced today an equity investment of $180 million and a new
strategic collaboration with Owkin comprised of discovery and
development programmes in four exclusive types of cancer, with a total
payment of $90 million for three years plus additional research
milestone-based payments.
More info >> |
|
 |
White Papers |
 |
|
Blockbuster Drugs Need Blockbuster Components
West Pharmaceutical Services, Inc.
Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
More info >> |
|
|
|
